HistCite - Trojanowski w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
1001	19190 Fredenburg RA, Rospigliosi C, Meray RK, Kessler JC, Lashuel HA, et al. The impact of the E46K mutation on the properties of alpha-synuclein in its monomeric and oligomeric states BIOCHEMISTRY. 2007 JUN 19; 46 (24): 7107-7118	28	35	42	58
1002	19687 Swerdlow RH Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging? NEUROBIOLOGY OF AGING. 2007 OCT; 28 (10): 1465-1480	8	20	42	226
1003	19880 Zibaee S, Jakes R, Fraser G, Serpell LC, Crowther RA, et al. Sequence determinants for amyloid fibrillogenesis of human alpha- synuclein JOURNAL OF MOLECULAR BIOLOGY. 2007 NOV 23; 374 (2): 454-464	14	15	42	56
1004	20875 Zhou W, Milder JB, Freed CR Transgenic mice overexpressing tyrosine-to-cysteine mutant human alpha- synuclein - A progressive neurodegenerative model of diffuse Lewy body disease JOURNAL OF BIOLOGICAL CHEMISTRY. 2008 APR 11; 283 (15): 9863-9870	6	8	42	47
1005	21032 Danielson SR, Andersen JK Oxidative and nitrative protein modifications in Parkinson's disease FREE RADICAL BIOLOGY AND MEDICINE. 2008 MAY 15; 44 (10): 1787-1794	7	31	42	105
1006	21105 Rahimi F, Shanmugam A, Bitan G Structure-function relationships of pre-fibrillar protein assemblies in Alzheimer's disease and related disorders CURRENT ALZHEIMER RESEARCH. 2008 JUN; 5 (3): 319-341	2	13	42	264
1007	21741 Matias-Guiu J, Garcia-Ramos R, Galan L, Barcia JA Neuronal death in amyotrofic lateral sclerosis NEUROLOGIA. 2008 OCT; 23 (8): 518-529	0	0	42	200
1008	21841 Gagnon JF, Petit D, Latreille V, Montplaisir J Neurobiology of Sleep Disturbances in Neurodegenerative Disorders CURRENT PHARMACEUTICAL DESIGN. 2008 NOV; 14 (32): 3430-3445	2	8	42	282
1009	23229 Lees AJ, Hardy J, Revesz T Parkinson's disease LANCET. 2009 JUN 13; 373 (9680): 2055-2066	17	70	42	132
1010	23321 Liem RKH, Messing A Dysfunctions of neuronal and glial intermediate filaments in disease JOURNAL OF CLINICAL INVESTIGATION. 2009 JUL; 119 (7): 1814-1824	0	7	42	127
#	Date / Author / Journal	LCS	GCS	LCR	CR
1011	23673 Maguire-Zeiss KA, Federoff HJ Immune-Directed Gene Therapeutic Development for Alzheimer's, Prion, and Parkinson's Diseases JOURNAL OF NEUROIMMUNE PHARMACOLOGY. 2009 SEP; 4 (3): 298-308	1	1	42	109
1012	23777 Tinsley RB, Bye CR, Parish CL, Tziotis-Vais A, George S, et al. Dopamine D-2 Receptor Knockout Mice Develop Features of Parkinson Disease ANNALS OF NEUROLOGY. 2009 OCT; 66 (4): 472-484	0	8	42	79
1013	23799 Chang E, Honson NS, Bandyopadhyay B, Funk KE, Jensen JR, et al. Modulation and Detection of Tau Aggregation with Small-Molecule Ligands CURRENT ALZHEIMER RESEARCH. 2009 OCT; 6 (5): 409-414	0	1	42	68
1014	23839 Eller M, Williams DR Biological fluid biomarkers in neurodegenerative parkinsonism NATURE REVIEWS NEUROLOGY. 2009 OCT; 5 (10): 561-570	4	7	42	93
1015	23981 Chen L, Periquet M, Wang X, Negro A, McLean PJ, et al. Tyrosine and serine phosphorylation of alpha-synuclein have opposing effects on neurotoxicity and soluble oligomer formation JOURNAL OF CLINICAL INVESTIGATION. 2009 NOV; 119 (11): 3257-3265	6	6	42	55
1016	24119 Outeiro TF, Ferreira J Current and Future Therapeutic Strategies for Parkinson's Disease CURRENT PHARMACEUTICAL DESIGN. 2009 DEC; 15 (34): 3968-3976	0	2	42	99
1017	24350 von Bernhardi R Immunotherapy in Alzheimer's Disease: Where Do We Stand? Where Should We Go? JOURNAL OF ALZHEIMERS DISEASE. 2010; 19 (2): 405-421	0	0	42	191
1018	25313 Brown DR Oligomeric Alpha-synuclein and Its Role in Neuronal Death IUBMB LIFE. 2010 MAY; 62 (5): 334-339	0	0	42	52
1019	25608 Sreedharan J Neuronal Death in Amyotrophic Lateral Sclerosis (ALS): What Can We Learn from Genetics? CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2010 JUL; 9 (3): 259-267	0	0	42	144
1020	25715 Baumer D, Ansorge O, Almeida M, Talbot K The role of RNA processing in the pathogenesis of motor neuron degeneration EXPERT REVIEWS IN MOLECULAR MEDICINE. 2010 JUL 20; 12: Art. No. e21	0	0	42	224
#	Date / Author / Journal	LCS	GCS	LCR	CR
1021	26044 Bulic B, Pickhardt M, Mandelkow EM, Mandelkow E Tau protein and tau aggregation inhibitors NEUROPHARMACOLOGY. 2010 SEP-OCT; 59 (4-5): 276-289	0	0	42	158
1022	26276 Middleton ER, Rhoades E Effects of Curvature and Composition on alpha-Synuclein Binding to Lipid Vesicles BIOPHYSICAL JOURNAL. 2010 OCT 6; 99 (7): 2279-2288	0	1	42	80
1023	26347 Jack CR, Wiste HJ, Vemuri P, Weigand SD, Senjem ML, et al. Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease BRAIN. 2010 NOV; 133: 3336-3348	2	2	42	121
1024	26641 Liachko NF, Guthrie CR, Kraemer BC Phosphorylation Promotes Neurotoxicity in a Caenorhabditis elegans Model of TDP-43 Proteinopathy JOURNAL OF NEUROSCIENCE. 2010 DEC 1; 30 (48): 16208-16219	0	0	42	59
1025	3588 MORISHIMAKAWASHIMA M, HASEGAWA M, TAKIO K, SUZUKI M, YOSHIDA H, et al. PROLINE-DIRECTED AND NON-PROLINE-DIRECTED PHOSPHORYLATION OF PHF-TAU JOURNAL OF BIOLOGICAL CHEMISTRY. 1995 JAN 13; 270 (2): 823-829	310	362	41	72
1026	3997 PREUSS U, DORING F, ILLENBERGER S, MANDELKOW EM CELL CYCLE-DEPENDENT PHOSPHORYLATION AND MICROTUBULE-BINDING OF TAU- PROTEIN STABLY TRANSFECTED INTO CHINESE-HAMSTER OVARY CELLS MOLECULAR BIOLOGY OF THE CELL. 1995 OCT; 6 (10): 1397-1410	52	74	41	79
1027	4292 Greenberg BD, Savage MJ, Howland DS, Ali SM, Siedlak SL, et al. APP transgenesis: Approaches toward the development of animal models for Alzheimer disease neuropathology NEUROBIOLOGY OF AGING. 1996 MAR-APR; 17 (2): 153-171	8	30	41	323
1028	5551 Hasegawa M, Crowther RA, Jakes B, Goedert M Alzheimer-like changes in microtubule-associated protein tau induced by sulfated glycosaminoglycans - Inhibition of microtubule binding, stimulation of phosphorylation, and filament assembly depend on the degree of sulfation JOURNAL OF BIOLOGICAL CHEMISTRY. 1997 DEC 26; 272 (52): 33118-33124	86	116	41	57
1029	6409 Spillantini MG, Goedert M Tau protein pathology in neurodegenerative diseases TRENDS IN NEUROSCIENCES. 1998 OCT; 21 (10): 428-433	270	360	41	66
1030	6963 Schneider A, Biernat J, von Bergen M, Mandelkow E, Mandelkow EM Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments BIOCHEMISTRY. 1999 MAR 23; 38 (12): 3549-3558	159	209	41	67
#	Date / Author / Journal	LCS	GCS	LCR	CR
1031	7471 Komori T Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick's disease BRAIN PATHOLOGY. 1999 OCT; 9 (4): 663-679	114	127	41	141
1032	7487 Larner AJ Tau protein as a therapeutic target in Alzheimer's disease and other neurodegenerative disorders EXPERT OPINION ON THERAPEUTIC PATENTS. 1999 OCT; 9 (10): 1359-1370	1	9	41	104
1033	7526 Clayton DF, George JM Synucleins in synaptic plasticity and neurodegenerative disorders JOURNAL OF NEUROSCIENCE RESEARCH. 1999 OCT 1; 58 (1): 120-129	186	216	41	85
1034	7662 Grundke-Iqbal I, Iqbal K Tau pathology generated by overexpression of tau AMERICAN JOURNAL OF PATHOLOGY. 1999 DEC; 155 (6): 1781-1785	6	11	41	75
1035	8082 Gong CX, Lidsky T, Wegiel J, Zuck L, Grundke-Iqbal I, et al. Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain - Implications for neurofibrillary degeneration in Alzheimer's disease JOURNAL OF BIOLOGICAL CHEMISTRY. 2000 FEB 25; 275 (8): 5535-5544	119	173	41	78
1036	8495 Duda JE, Lee VMY, Trojanowski JQ Neuropathology of synuclein aggregates: New insights into mechanisms of neurodegenerative diseases JOURNAL OF NEUROSCIENCE RESEARCH. 2000 JUL 15; 61 (2): 121-127	147	147	41	52
1037	9857 Planel E, Yasutake K, Fujita SC, Ishiguro K Inhibition of protein phosphatase 2A overrides tau protein kinase I/glycogen synthase kinase 3 beta and cyclin-dependent kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse JOURNAL OF BIOLOGICAL CHEMISTRY. 2001 SEP 7; 276 (36): 34298-34306	56	91	41	72
1038	10009 Longhi L, Saatman KE, Raghupathi R, Laurer HL, Lenzlinger PM, et al. A review and rationale for the use of genetically engineered animals in the study of traumatic brain injury JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2001 NOV; 21 (11): 1241-1258	22	22	41	145
1039	10321 Fernyhough P, Schmidt RE Neurofilaments in diabetic neuropathy NEUROBIOLOGY OF DIABETIC NEUROPATHY. 2002; 50: 115-144	0	11	41	148
1040	10864 Lansbury PT, Brice A Genetics of Parkinson's disease and biochemical studies of implicated gene products CURRENT OPINION IN GENETICS & DEVELOPMENT. 2002 JUN; 12 (3): 299-306	32	47	41	79
#	Date / Author / Journal	LCS	GCS	LCR	CR
1041	11342 Masliah E, Hashimoto M Development of new treatments for Parkinson's disease in transgenic animal models: A role for beta-synuclein NEUROTOXICOLOGY. 2002 OCT; 23 (4-5): 461-468	10	16	41	58
1042	11800 Maguire-Zeiss KA, Federoff HJ Convergent pathobiologic model of Parkinson's disease PARKINSON'S DISEASE: THE LIFE CYCLE OF THE DOPAMINE NEURON. 2003; 991: 152-166	17	27	41	83
1043	12424 Quilty MC, Gai WP, Pountney DL, West AK, Vickers JC Localization of alpha-, beta-, and gamma-synuclein during neuronal development and alterations associated with the neuronal response to axonal trauma EXPERIMENTAL NEUROLOGY. 2003 JUL; 182 (1): 195-207	19	22	41	50
1044	12464 Rao MV, Nixon RA Defective neurofilament transport in mouse models of amyotrophic lateral sclerosis: A review NEUROCHEMICAL RESEARCH. 2003 JUL; 28 (7): 1041-1047	17	39	41	93
1045	12869 Shipp S The functional logic of cortico-pulvinar connections PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES. 2003 OCT 29; 358 (1438): 1605-1624	3	52	41	129
1046	13158 Milton NGN Role of hydrogen peroxide in the aetiology of Alzheimer's disease - Implications for treatment DRUGS & AGING. 2004; 21 (2): 81-100	3	34	41	244
1047	13173 Gervasi C, Szaro BG Performing functional studies of Xenopus laevis intermediate filament proteins through injection of macromolecules into early embryos INTERMEDIATE FILAMENT CYTOSKELETON. 2004; 78: 673-701	0	1	41	118
1048	13942 Perez RG, Hastings TG Could a loss of alpha-synuclein function put dopaminergic neurons at risk? JOURNAL OF NEUROCHEMISTRY. 2004 JUN; 89 (6): 1318-1324	34	44	41	79
1049	14090 Adlard PA, Cummings BJ Alzheimer's disease - a sum greater than its parts? NEUROBIOLOGY OF AGING. 2004 JUL; 25 (6): 725-733	0	3	41	128
1050	14204 Haddad JJ Mitogen-activated protein kinases and the evolution of Alzheimer's: a revolutionary neurogenetic axis for therapeutic intervention? PROGRESS IN NEUROBIOLOGY. 2004 AUG; 73 (5): 359-377	3	22	41	204
#	Date / Author / Journal	LCS	GCS	LCR	CR
1051	14815 Zhu XW, Lee HG, Casadesus G, Avila J, Drew K, et al. Oxidative imbalance in Alzheimer's disease MOLECULAR NEUROBIOLOGY. 2005; 31 (1-3): 205-217	16	43	41	135
1052	14967 Feinstein SC, Wilson L Inability of tau to properly regulate neuronal microtubule dynamics: a loss-of-function mechanism by which tau might mediate neuronal cell death BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2005 JAN 3; 1739 (2-3): 268-279	33	49	41	97
1053	14989 Feijoo C, Campbell DG, Jakes R, Goedert M, Cuenda A Evidence that phosphorylation of the microtubule-associated protein Tau by SAPK4/p38 delta at Thr50 promotes microtubule assembly JOURNAL OF CELL SCIENCE. 2005 JAN 15; 118 (2): 397-408	11	29	41	64
1054	15232 Uversky VN, Yamin G, Munishkina LA, Karymov MA, Millett IS, et al. Effects of nitration on the structure and aggregation of alpha- synuclein MOLECULAR BRAIN RESEARCH. 2005 MAR 24; 134 (1): 84-102	31	9	41	81
1055	16170 Miyasaka T, Ding Z, Gengyo-Ando K, Oue M, Yamaguchi H, et al. Progressive neurodegeneration in C-elegans model of tauopathy NEUROBIOLOGY OF DISEASE. 2005 NOV; 20 (2): 372-383	19	20	41	64
1056	16336 Lin H, Zhai J, Schlaepfer WW RNA-binding protein is involved in aggregation of light neurofilament protein and is implicated in the pathogenesis of motor neuron degeneration HUMAN MOLECULAR GENETICS. 2005 DEC 1; 14 (23): 3643-3659	10	19	41	94
1057	16992 Papadopoulos D, Ewans L, Pham-Dinh D, Knott J, Reynolds R Upregulation of alpha-synuclein in neurons and glia in inflammatory demyelinating disease MOLECULAR AND CELLULAR NEUROSCIENCE. 2006 APR; 31 (4): 597-612	10	12	41	64
1058	16998 Mattson MP, Magnus T Ageing and neuronal vulnerability NATURE REVIEWS NEUROSCIENCE. 2006 APR; 7 (4): 278-294	25	146	41	225
1059	17152 Alonso-Navarro H, Jabbour-Wadih T, Ayuso-Peralta L, Jimenez-Jimenez FJ The neurochemistry and neuropharmacology of frontotemporal dementia REVISTA DE NEUROLOGIA. 2006 MAY 1; 42 (9): 556-561	1	1	41	94
1060	17470 Bar-On P, Rockenstein E, Adame A, Ho G, Hashimoto M, et al. Effects of the cholesterol-lowering compound methyl-beta-cyclodextrin in models of alpha-synucleinopathy JOURNAL OF NEUROCHEMISTRY. 2006 AUG; 98 (4): 1032-1045	11	19	41	89
#	Date / Author / Journal	LCS	GCS	LCR	CR
1061	18494 Sang TK, Chang HY, Lawless GM, Ratnaparkhi A, Mee L, et al. A Drosophila model of mutant human parkin-induced toxicity demonstrates selective loss of dopaminergic neurons and dependence on cellular dopamine JOURNAL OF NEUROSCIENCE. 2007 JAN 31; 27 (5): 981-992	23	36	41	109
1062	18779 Spina S, Murrell JR, Yoshida H, Ghetti B, Bermingham N, et al. The novel Tau mutation G335S: clinical, neuropathological and molecular characterization ACTA NEUROPATHOLOGICA. 2007 APR; 113 (4): 461-470	3	3	41	47
1063	18903 Ferreon ACM, Deniz AA alpha-Synuclein multistate folding thermodynamics: Implications for protein misfolding and aggregation BIOCHEMISTRY. 2007 APR 17; 46 (15): 4499-4509	18	28	41	68
1064	19304 Yamashita H, Matsumoto M Molecular pathogenesis, experimental models and new therapeutic strategies for Parkinson's disease REGENERATIVE MEDICINE. 2007 JUL; 2 (4): 447-455	0	5	41	81
1065	19376 Stewart AJ, Fox A, Morimoto BH, Gozes I Looking for novel ways to treat the hallmarks of Alzheimer's disease EXPERT OPINION ON INVESTIGATIONAL DRUGS. 2007 AUG; 16 (8): 1183-1196	4	10	41	143
1066	19558 Butterfield DA, Reed T, Newman SF, Sultana R Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment FREE RADICAL BIOLOGY AND MEDICINE. 2007 SEP 1; 43 (5): 658-677	18	91	41	268
1067	19691 Snowden JS, Pickering-Brown SM, Du Plessis D, Mackenzie IRA, Varma A, et al. Progressive anomia revisited: Focal degeneration associated with progranulin gene mutation NEUROCASE. 2007 OCT-DEC; 13 (5-6): 366-377	1	4	41	78
1068	19891 Assayag K, Yakunin E, Loeb V, Selkoe DJ, Sharon R Polyunsaturated fatty acids induce alpha-synuclein-related pathogenic changes in neuronal cells AMERICAN JOURNAL OF PATHOLOGY. 2007 DEC; 171 (6): 2000-2011	10	13	41	67
1069	20019 Fornai F Novel therapeutic target in PD: Experimental models ADVANCES IN ALZHEIMER'S AND PARKINSON'S DISEASE: INSIGHTS, PROGRESS, AND PERSPECTIVES. 2008; 57: 57-73	0	0	41	88
1070	20136 Brunden KR, Trojanowski JQ, Lee VMY Evidence that non-fibrillar tau causes pathology linked to neurodegeneration and behavioral impairments JOURNAL OF ALZHEIMERS DISEASE. 2008; 14 (4): 393-399	17	17	41	59
#	Date / Author / Journal	LCS	GCS	LCR	CR
1071	20201 Cassel JC, Mathis C, Majchrzak M, Moreau PH, Dalrymple-Alford JC Coexisting cholinergic and parahippocampal degeneration: A key to memory loss in dementia and a challenge for transgenic models? NEURODEGENERATIVE DISEASES. 2008; 5 (5): 304-317	1	7	41	161
1072	21503 Sugeno N, Takeda A, Hasegawa T, Kobayashi M, Kikuchi A, et al. Serine 129 phosphorylation of alpha-synuclein induces unfolded protein response-mediated cell death JOURNAL OF BIOLOGICAL CHEMISTRY. 2008 AUG 22; 283 (34): 23179-23188	15	18	41	65
1073	21879 Su XM, Maguire-Zeiss KA, Giuliano R, Prifti L, Venkatesh K, et al. Synuclein activates microglia in a model of Parkinson's disease NEUROBIOLOGY OF AGING. 2008 NOV; 29 (11): 1690-1701	26	34	41	84
1074	21988 Devine MJ, Lewis PA Emerging pathways in genetic Parkinson's disease: tangles, Lewy bodies and LRRK2 FEBS JOURNAL. 2008 DEC; 275 (23): 5748-5757	4	7	41	79
1075	23247 Sun Q, Gamblin TC Pseudohyperphosphorylation Causing AD-like Changes in Tau Has Significant Effects on Its Polymerization BIOCHEMISTRY. 2009 JUN 30; 48 (25): 6002-6011	1	2	41	61
1076	23273 Gasser T Mendelian forms of Parkinson's disease BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2009 JUL; 1792 (7): 587-596	6	13	41	154
1077	23415 Rao JN, Kim YE, Park LS, Ulmer TS Effect of Pseudorepeat Rearrangement on alpha-Synuclein Misfolding, Vesicle Binding, and Micelle Binding JOURNAL OF MOLECULAR BIOLOGY. 2009 JUL 17; 390 (3): 516-529	3	4	41	77
1078	23676 Mitchell AJ CSF phosphorylated tau in the diagnosis and prognosis of mild cognitive impairment and Alzheimer's disease: a meta-analysis of 51 studies JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2009 SEP; 80 (9): 966-975	1	4	41	74
1079	23793 Scott LE, Orvig C Medicinal Inorganic Chemistry Approaches to Passivation and Removal of Aberrant Metal Ions in Disease CHEMICAL REVIEWS. 2009 OCT; 109 (10): 4885-4910	1	20	41	326
1080	23956 Whitwell JL, Przybelski SA, Weigand SD, Ivnik RJ, Vemuri P, et al. Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: a cluster analysis study BRAIN. 2009 NOV; 132: 2932-2946	6	7	41	94
#	Date / Author / Journal	LCS	GCS	LCR	CR
1081	24558 Nelson PT, Abner EL, Schmitt FA, Kryscio RJ, Jicha GA, et al. Modeling the Association between 43 Different Clinical and Pathological Variables and the Severity of Cognitive Impairment in a Large Autopsy Cohort of Elderly Persons BRAIN PATHOLOGY. 2010 JAN; 20 (1): 66-79	3	4	41	129
1082	24601 Gabelle A, Portet F, Berr C, Touchon J NEURODEGENERATIVE DEMENTIA AND PARKINSONISM JOURNAL OF NUTRITION HEALTH & AGING. 2010 JAN; 14 (1): 37-44	0	1	41	78
1083	24608 Jack CR, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade LANCET NEUROLOGY. 2010 JAN; 9 (1): 119-128	77	76	41	116
1084	24616 Metcalfe MJ, Figueiredo-Pereira ME Relationship Between Tau Pathology and Neuroinflammation in Alzheimer's Disease MOUNT SINAI JOURNAL OF MEDICINE. 2010 JAN-FEB; 77 (1): 50-58	0	1	41	59
1085	24905 Zhou WB, Long CM, Reaney SH, Di Monte DA, Fink AL, et al. Methionine oxidation stabilizes non-toxic oligomers of alpha-synuclein through strengthening the auto-inhibitory intra-molecular long-range interactions BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2010 MAR; 1802 (3): 322-330	3	5	41	52
1086	25384 Giehm L, Otzen DE Strategies to increase the reproducibility of protein fibrillization in plate reader assays ANALYTICAL BIOCHEMISTRY. 2010 MAY 15; 400 (2): 270-281	1	1	41	77
1087	25490 Gu ZZ, Nakamura T, Lipton SA Redox Reactions Induced by Nitrosative Stress Mediate Protein Misfolding and Mitochondrial Dysfunction in Neurodegenerative Diseases MOLECULAR NEUROBIOLOGY. 2010 JUN; 41 (2-3): 55-72	2	5	41	196
1088	25494 Frautschy SA, Cole GM Why Pleiotropic Interventions are Needed for Alzheimer's Disease MOLECULAR NEUROBIOLOGY. 2010 JUN; 41 (2-3): 392-409	1	3	41	201
1089	25867 Suarez I, Bodega G, Fernandez B Upregulation of alpha-synuclein expression in the rat cerebellum in experimental hepatic encephalopathy NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2010 AUG; 36 (5): 422-435	0	0	41	59
1090	26370 Bandyopadhyay S, Huang XD, Lahiri DK, Rogers JT Novel drug targets based on metallobiology of Alzheimer's disease EXPERT OPINION ON THERAPEUTIC TARGETS. 2010 NOV; 14 (11): 1177-1197	0	0	41	230
#	Date / Author / Journal	LCS	GCS	LCR	CR
1091	26403 Dubois B, Feldman HH, Jacova C, Cummings JL, DeKosky ST, et al. Revising the definition of Alzheimer's disease: a new lexicon LANCET NEUROLOGY. 2010 NOV; 9 (11): 1118-1127	1	4	41	93
1092	26611 Hasegawa T, Baba T, Kobayashi M, Konno M, Sugeno N, et al. Role of TPPP/p25 on alpha-synuclein-mediated oligodendroglial degeneration and the protective effect of SIRT2 inhibition in a cellular model of multiple system atrophy NEUROCHEMISTRY INTERNATIONAL. 2010 DEC; 57 (8): 857-866	0	0	41	67
1093	26877 Mackenzie IRA, Munoz DG, Kusaka H, Yokota O, Ishihara K, et al. Distinct pathological subtypes of FTLD-FUS ACTA NEUROPATHOLOGICA. 2011 FEB; 121 (2): 207-218	0	0	41	62
1094	26903 Ballatore C, Brunden KR, Trojanowski JQ, Lee VMY, Smith AB, et al. Modulation of Protein-Protein Interactions as a Therapeutic Strategy for the Treatment of Neurodegenerative Tauopathies CURRENT TOPICS IN MEDICINAL CHEMISTRY. 2011 FEB; 11 (3): 317-330	0	0	41	130
1095	3779 YEN SH, LIU WK, HALL FL, YAN SD, STERN D, et al. ALZHEIMER NEUROFIBRILLARY LESIONS - MOLECULAR NATURE AND POTENTIAL ROLES OF DIFFERENT COMPONENTS NEUROBIOLOGY OF AGING. 1995 MAY-JUN; 16 (3): 381-387	21	36	40	92
1096	3780 ANDERTON BH, BRION JP, COUCK AM, DAVIS DR, GALLO JM, et al. MODULATION OF PHF-LIKE TAU PHOSPHORYLATION IN CULTURED NEURONS AND TRANSFECTED CELLS NEUROBIOLOGY OF AGING. 1995 MAY-JUN; 16 (3): 389-397	13	31	40	67
1097	5682 Shea TB, Didier M Biphasic effects of phosphatase inhibition on accumulation of tau phospho-isoforms in cultured cerebellar neurons NEUROSCIENCE RESEARCH COMMUNICATIONS. 1998 JAN-FEB; 22 (1): 39-44	1	1	40	56
1098	5862 Ince PG, Perry EK, Morris CM Dementia with Lewy bodies. A distinct non-Alzheimer dementia syndrome? BRAIN PATHOLOGY. 1998 APR; 8 (2): 299-324	61	83	40	278
1099	6764 Jicha GA, O'Donnell A, Weaver C, Angeletti R, Davies P Hierarchical phosphorylation of recombinant tau by the paired-helical filament-associated protein kinase is dependent on cyclic AMP-dependent protein kinase JOURNAL OF NEUROCHEMISTRY. 1999 JAN; 72 (1): 214-224	31	40	40	70
1100	7111 Kampers T, Pangalos M, Geerts H, Wiech H, Mandelkow E Assembly of paired helical filaments from mouse tau: implications for the neurofibrillary pathology in transgenic mouse models for Alzheimer's disease FEBS LETTERS. 1999 MAY 14; 451 (1): 39-44	21	26	40	73

Date / Author / Journal

LCS

GCS

LCR

1001

19190 Fredenburg RA, Rospigliosi C, Meray RK, Kessler JC, Lashuel HA, et al.

The impact of the E46K mutation on the properties of alpha-synuclein in its monomeric and oligomeric states

BIOCHEMISTRY. 2007 JUN 19; 46 (24): 7107-7118

1002

19687 Swerdlow RH

Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?

NEUROBIOLOGY OF AGING. 2007 OCT; 28 (10): 1465-1480

226

1003

19880 Zibaee S, Jakes R, Fraser G, Serpell LC, Crowther RA, et al.

Sequence determinants for amyloid fibrillogenesis of human alpha- synuclein

JOURNAL OF MOLECULAR BIOLOGY. 2007 NOV 23; 374 (2): 454-464

1004

20875 Zhou W, Milder JB, Freed CR

Transgenic mice overexpressing tyrosine-to-cysteine mutant human alpha- synuclein - A progressive neurodegenerative model of diffuse Lewy body disease

JOURNAL OF BIOLOGICAL CHEMISTRY. 2008 APR 11; 283 (15): 9863-9870

1005

21032 Danielson SR, Andersen JK

Oxidative and nitrative protein modifications in Parkinson's disease

FREE RADICAL BIOLOGY AND MEDICINE. 2008 MAY 15; 44 (10): 1787-1794

105

1006

21105 Rahimi F, Shanmugam A, Bitan G

Structure-function relationships of pre-fibrillar protein assemblies in Alzheimer's disease and related disorders

CURRENT ALZHEIMER RESEARCH. 2008 JUN; 5 (3): 319-341

264

1007

21741 Matias-Guiu J, Garcia-Ramos R, Galan L, Barcia JA

Neuronal death in amyotrofic lateral sclerosis

NEUROLOGIA. 2008 OCT; 23 (8): 518-529

200

1008

21841 Gagnon JF, Petit D, Latreille V, Montplaisir J

Neurobiology of Sleep Disturbances in Neurodegenerative Disorders

CURRENT PHARMACEUTICAL DESIGN. 2008 NOV; 14 (32): 3430-3445

282

1009

23229 Lees AJ, Hardy J, Revesz T

Parkinson's disease

LANCET. 2009 JUN 13; 373 (9680): 2055-2066

132

1010

23321 Liem RKH, Messing A

Dysfunctions of neuronal and glial intermediate filaments in disease

JOURNAL OF CLINICAL INVESTIGATION. 2009 JUL; 119 (7): 1814-1824

127

Date / Author / Journal

LCS

GCS

LCR

1011

23673 Maguire-Zeiss KA, Federoff HJ

Immune-Directed Gene Therapeutic Development for Alzheimer's, Prion, and Parkinson's Diseases

JOURNAL OF NEUROIMMUNE PHARMACOLOGY. 2009 SEP; 4 (3): 298-308

109

1012

23777 Tinsley RB, Bye CR, Parish CL, Tziotis-Vais A, George S, et al.

Dopamine D-2 Receptor Knockout Mice Develop Features of Parkinson Disease

ANNALS OF NEUROLOGY. 2009 OCT; 66 (4): 472-484

1013

23799 Chang E, Honson NS, Bandyopadhyay B, Funk KE, Jensen JR, et al.

Modulation and Detection of Tau Aggregation with Small-Molecule Ligands

CURRENT ALZHEIMER RESEARCH. 2009 OCT; 6 (5): 409-414

1014

23839 Eller M, Williams DR

Biological fluid biomarkers in neurodegenerative parkinsonism

NATURE REVIEWS NEUROLOGY. 2009 OCT; 5 (10): 561-570

1015

23981 Chen L, Periquet M, Wang X, Negro A, McLean PJ, et al.

Tyrosine and serine phosphorylation of alpha-synuclein have opposing effects on neurotoxicity and soluble oligomer formation

JOURNAL OF CLINICAL INVESTIGATION. 2009 NOV; 119 (11): 3257-3265

1016

24119 Outeiro TF, Ferreira J

Current and Future Therapeutic Strategies for Parkinson's Disease

CURRENT PHARMACEUTICAL DESIGN. 2009 DEC; 15 (34): 3968-3976

1017

24350 von Bernhardi R

Immunotherapy in Alzheimer's Disease: Where Do We Stand? Where Should We Go?

JOURNAL OF ALZHEIMERS DISEASE. 2010; 19 (2): 405-421

191

1018

25313 Brown DR

Oligomeric Alpha-synuclein and Its Role in Neuronal Death

IUBMB LIFE. 2010 MAY; 62 (5): 334-339

1019

25608 Sreedharan J

Neuronal Death in Amyotrophic Lateral Sclerosis (ALS): What Can We Learn from Genetics?

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2010 JUL; 9 (3): 259-267

144

1020

25715 Baumer D, Ansorge O, Almeida M, Talbot K

The role of RNA processing in the pathogenesis of motor neuron degeneration

EXPERT REVIEWS IN MOLECULAR MEDICINE. 2010 JUL 20; 12: Art. No. e21

224

Date / Author / Journal

LCS

GCS

LCR

1021

26044 Bulic B, Pickhardt M, Mandelkow EM, Mandelkow E

Tau protein and tau aggregation inhibitors

NEUROPHARMACOLOGY. 2010 SEP-OCT; 59 (4-5): 276-289

158

1022

26276 Middleton ER, Rhoades E

Effects of Curvature and Composition on alpha-Synuclein Binding to Lipid Vesicles

BIOPHYSICAL JOURNAL. 2010 OCT 6; 99 (7): 2279-2288

1023

26347 Jack CR, Wiste HJ, Vemuri P, Weigand SD, Senjem ML, et al.

Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease

BRAIN. 2010 NOV; 133: 3336-3348

121

1024

26641 Liachko NF, Guthrie CR, Kraemer BC

Phosphorylation Promotes Neurotoxicity in a Caenorhabditis elegans Model of TDP-43 Proteinopathy

JOURNAL OF NEUROSCIENCE. 2010 DEC 1; 30 (48): 16208-16219

1025

3588 MORISHIMAKAWASHIMA M, HASEGAWA M, TAKIO K, SUZUKI M, YOSHIDA H, et al.

PROLINE-DIRECTED AND NON-PROLINE-DIRECTED PHOSPHORYLATION OF PHF-TAU

JOURNAL OF BIOLOGICAL CHEMISTRY. 1995 JAN 13; 270 (2): 823-829

310

362

1026

3997 PREUSS U, DORING F, ILLENBERGER S, MANDELKOW EM

CELL CYCLE-DEPENDENT PHOSPHORYLATION AND MICROTUBULE-BINDING OF TAU- PROTEIN STABLY TRANSFECTED INTO CHINESE-HAMSTER OVARY CELLS

MOLECULAR BIOLOGY OF THE CELL. 1995 OCT; 6 (10): 1397-1410

1027

4292 Greenberg BD, Savage MJ, Howland DS, Ali SM, Siedlak SL, et al.

APP transgenesis: Approaches toward the development of animal models for Alzheimer disease neuropathology

NEUROBIOLOGY OF AGING. 1996 MAR-APR; 17 (2): 153-171

323

1028

5551 Hasegawa M, Crowther RA, Jakes B, Goedert M

Alzheimer-like changes in microtubule-associated protein tau induced by sulfated glycosaminoglycans - Inhibition of microtubule binding, stimulation of phosphorylation, and filament assembly depend on the degree of sulfation

JOURNAL OF BIOLOGICAL CHEMISTRY. 1997 DEC 26; 272 (52): 33118-33124

116

1029

6409 Spillantini MG, Goedert M

Tau protein pathology in neurodegenerative diseases

TRENDS IN NEUROSCIENCES. 1998 OCT; 21 (10): 428-433

270

360

1030

6963 Schneider A, Biernat J, von Bergen M, Mandelkow E, Mandelkow EM

Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments

BIOCHEMISTRY. 1999 MAR 23; 38 (12): 3549-3558

159

209

Date / Author / Journal

1031

Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick's disease

BRAIN PATHOLOGY. 1999 OCT; 9 (4): 663-679

114

127

141

1032

7487 Larner AJ

Tau protein as a therapeutic target in Alzheimer's disease and other neurodegenerative disorders

EXPERT OPINION ON THERAPEUTIC PATENTS. 1999 OCT; 9 (10): 1359-1370

104

1033

7526 Clayton DF, George JM

Synucleins in synaptic plasticity and neurodegenerative disorders

JOURNAL OF NEUROSCIENCE RESEARCH. 1999 OCT 1; 58 (1): 120-129

186

216

1034

7662 Grundke-Iqbal I, Iqbal K

Tau pathology generated by overexpression of tau

AMERICAN JOURNAL OF PATHOLOGY. 1999 DEC; 155 (6): 1781-1785

1035

8082 Gong CX, Lidsky T, Wegiel J, Zuck L, Grundke-Iqbal I, et al.

Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain - Implications for neurofibrillary degeneration in Alzheimer's disease

JOURNAL OF BIOLOGICAL CHEMISTRY. 2000 FEB 25; 275 (8): 5535-5544

119

173

1036

8495 Duda JE, Lee VMY, Trojanowski JQ

Neuropathology of synuclein aggregates: New insights into mechanisms of neurodegenerative diseases

JOURNAL OF NEUROSCIENCE RESEARCH. 2000 JUL 15; 61 (2): 121-127

147

1037

9857 Planel E, Yasutake K, Fujita SC, Ishiguro K

Inhibition of protein phosphatase 2A overrides tau protein kinase I/glycogen synthase kinase 3 beta and cyclin-dependent kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse

JOURNAL OF BIOLOGICAL CHEMISTRY. 2001 SEP 7; 276 (36): 34298-34306

1038

10009 Longhi L, Saatman KE, Raghupathi R, Laurer HL, Lenzlinger PM, et al.

A review and rationale for the use of genetically engineered animals in the study of traumatic brain injury

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2001 NOV; 21 (11): 1241-1258

145

1039

10321 Fernyhough P, Schmidt RE

Neurofilaments in diabetic neuropathy

NEUROBIOLOGY OF DIABETIC NEUROPATHY. 2002; 50: 115-144

148

1040

10864 Lansbury PT, Brice A

Genetics of Parkinson's disease and biochemical studies of implicated gene products

CURRENT OPINION IN GENETICS & DEVELOPMENT. 2002 JUN; 12 (3): 299-306

Date / Author / Journal

LCS

GCS

LCR

1041

11342 Masliah E, Hashimoto M

Development of new treatments for Parkinson's disease in transgenic animal models: A role for beta-synuclein

NEUROTOXICOLOGY. 2002 OCT; 23 (4-5): 461-468

1042

11800 Maguire-Zeiss KA, Federoff HJ

Convergent pathobiologic model of Parkinson's disease

PARKINSON'S DISEASE: THE LIFE CYCLE OF THE DOPAMINE NEURON. 2003; 991: 152-166

1043

12424 Quilty MC, Gai WP, Pountney DL, West AK, Vickers JC

Localization of alpha-, beta-, and gamma-synuclein during neuronal development and alterations associated with the neuronal response to axonal trauma

EXPERIMENTAL NEUROLOGY. 2003 JUL; 182 (1): 195-207

1044

12464 Rao MV, Nixon RA

Defective neurofilament transport in mouse models of amyotrophic lateral sclerosis: A review

NEUROCHEMICAL RESEARCH. 2003 JUL; 28 (7): 1041-1047

1045

12869 Shipp S

The functional logic of cortico-pulvinar connections

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES. 2003 OCT 29; 358 (1438): 1605-1624

129

1046

13158 Milton NGN

Role of hydrogen peroxide in the aetiology of Alzheimer's disease - Implications for treatment

DRUGS & AGING. 2004; 21 (2): 81-100

244

1047

13173 Gervasi C, Szaro BG

Performing functional studies of Xenopus laevis intermediate filament proteins through injection of macromolecules into early embryos

INTERMEDIATE FILAMENT CYTOSKELETON. 2004; 78: 673-701

118

1048

13942 Perez RG, Hastings TG

Could a loss of alpha-synuclein function put dopaminergic neurons at risk?

JOURNAL OF NEUROCHEMISTRY. 2004 JUN; 89 (6): 1318-1324

1049

14090 Adlard PA, Cummings BJ

Alzheimer's disease - a sum greater than its parts?

NEUROBIOLOGY OF AGING. 2004 JUL; 25 (6): 725-733

128

1050

14204 Haddad JJ

Mitogen-activated protein kinases and the evolution of Alzheimer's: a revolutionary neurogenetic axis for therapeutic intervention?

PROGRESS IN NEUROBIOLOGY. 2004 AUG; 73 (5): 359-377

204

Date / Author / Journal

LCS

GCS

LCR

1051

14815 Zhu XW, Lee HG, Casadesus G, Avila J, Drew K, et al.

Oxidative imbalance in Alzheimer's disease

MOLECULAR NEUROBIOLOGY. 2005; 31 (1-3): 205-217

135

1052

14967 Feinstein SC, Wilson L

Inability of tau to properly regulate neuronal microtubule dynamics: a loss-of-function mechanism by which tau might mediate neuronal cell death

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2005 JAN 3; 1739 (2-3): 268-279

1053

14989 Feijoo C, Campbell DG, Jakes R, Goedert M, Cuenda A

Evidence that phosphorylation of the microtubule-associated protein Tau by SAPK4/p38 delta at Thr50 promotes microtubule assembly

JOURNAL OF CELL SCIENCE. 2005 JAN 15; 118 (2): 397-408

1054

15232 Uversky VN, Yamin G, Munishkina LA, Karymov MA, Millett IS, et al.

Effects of nitration on the structure and aggregation of alpha- synuclein

MOLECULAR BRAIN RESEARCH. 2005 MAR 24; 134 (1): 84-102

1055

16170 Miyasaka T, Ding Z, Gengyo-Ando K, Oue M, Yamaguchi H, et al.

Progressive neurodegeneration in C-elegans model of tauopathy

NEUROBIOLOGY OF DISEASE. 2005 NOV; 20 (2): 372-383

1056

16336 Lin H, Zhai J, Schlaepfer WW

RNA-binding protein is involved in aggregation of light neurofilament protein and is implicated in the pathogenesis of motor neuron degeneration

HUMAN MOLECULAR GENETICS. 2005 DEC 1; 14 (23): 3643-3659

1057

16992 Papadopoulos D, Ewans L, Pham-Dinh D, Knott J, Reynolds R

Upregulation of alpha-synuclein in neurons and glia in inflammatory demyelinating disease

MOLECULAR AND CELLULAR NEUROSCIENCE. 2006 APR; 31 (4): 597-612

1058

16998 Mattson MP, Magnus T

Ageing and neuronal vulnerability

NATURE REVIEWS NEUROSCIENCE. 2006 APR; 7 (4): 278-294

146

225

1059

17152 Alonso-Navarro H, Jabbour-Wadih T, Ayuso-Peralta L, Jimenez-Jimenez FJ

The neurochemistry and neuropharmacology of frontotemporal dementia

REVISTA DE NEUROLOGIA. 2006 MAY 1; 42 (9): 556-561

1060

17470 Bar-On P, Rockenstein E, Adame A, Ho G, Hashimoto M, et al.

Effects of the cholesterol-lowering compound methyl-beta-cyclodextrin in models of alpha-synucleinopathy

JOURNAL OF NEUROCHEMISTRY. 2006 AUG; 98 (4): 1032-1045

Date / Author / Journal

LCS

GCS

LCR

1061

18494 Sang TK, Chang HY, Lawless GM, Ratnaparkhi A, Mee L, et al.

A Drosophila model of mutant human parkin-induced toxicity demonstrates selective loss of dopaminergic neurons and dependence on cellular dopamine

JOURNAL OF NEUROSCIENCE. 2007 JAN 31; 27 (5): 981-992

109

1062

18779 Spina S, Murrell JR, Yoshida H, Ghetti B, Bermingham N, et al.

The novel Tau mutation G335S: clinical, neuropathological and molecular characterization

ACTA NEUROPATHOLOGICA. 2007 APR; 113 (4): 461-470

1063

18903 Ferreon ACM, Deniz AA

alpha-Synuclein multistate folding thermodynamics: Implications for protein misfolding and aggregation

BIOCHEMISTRY. 2007 APR 17; 46 (15): 4499-4509

1064

19304 Yamashita H, Matsumoto M

Molecular pathogenesis, experimental models and new therapeutic strategies for Parkinson's disease

REGENERATIVE MEDICINE. 2007 JUL; 2 (4): 447-455

1065

19376 Stewart AJ, Fox A, Morimoto BH, Gozes I

Looking for novel ways to treat the hallmarks of Alzheimer's disease

EXPERT OPINION ON INVESTIGATIONAL DRUGS. 2007 AUG; 16 (8): 1183-1196

143

1066

19558 Butterfield DA, Reed T, Newman SF, Sultana R

Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment

FREE RADICAL BIOLOGY AND MEDICINE. 2007 SEP 1; 43 (5): 658-677

268

1067

19691 Snowden JS, Pickering-Brown SM, Du Plessis D, Mackenzie IRA, Varma A, et al.

Progressive anomia revisited: Focal degeneration associated with progranulin gene mutation

NEUROCASE. 2007 OCT-DEC; 13 (5-6): 366-377

1068

19891 Assayag K, Yakunin E, Loeb V, Selkoe DJ, Sharon R

Polyunsaturated fatty acids induce alpha-synuclein-related pathogenic changes in neuronal cells

AMERICAN JOURNAL OF PATHOLOGY. 2007 DEC; 171 (6): 2000-2011

1069

20019 Fornai F

Novel therapeutic target in PD: Experimental models

ADVANCES IN ALZHEIMER'S AND PARKINSON'S DISEASE: INSIGHTS, PROGRESS, AND PERSPECTIVES. 2008; 57: 57-73

1070

20136 Brunden KR, Trojanowski JQ, Lee VMY

Evidence that non-fibrillar tau causes pathology linked to neurodegeneration and behavioral impairments

JOURNAL OF ALZHEIMERS DISEASE. 2008; 14 (4): 393-399

Date / Author / Journal

LCS

GCS

LCR

1071

20201 Cassel JC, Mathis C, Majchrzak M, Moreau PH, Dalrymple-Alford JC

Coexisting cholinergic and parahippocampal degeneration: A key to memory loss in dementia and a challenge for transgenic models?

NEURODEGENERATIVE DISEASES. 2008; 5 (5): 304-317

161

1072

21503 Sugeno N, Takeda A, Hasegawa T, Kobayashi M, Kikuchi A, et al.

Serine 129 phosphorylation of alpha-synuclein induces unfolded protein response-mediated cell death

JOURNAL OF BIOLOGICAL CHEMISTRY. 2008 AUG 22; 283 (34): 23179-23188

1073

21879 Su XM, Maguire-Zeiss KA, Giuliano R, Prifti L, Venkatesh K, et al.

Synuclein activates microglia in a model of Parkinson's disease

NEUROBIOLOGY OF AGING. 2008 NOV; 29 (11): 1690-1701

1074

21988 Devine MJ, Lewis PA

Emerging pathways in genetic Parkinson's disease: tangles, Lewy bodies and LRRK2

FEBS JOURNAL. 2008 DEC; 275 (23): 5748-5757

1075

23247 Sun Q, Gamblin TC

Pseudohyperphosphorylation Causing AD-like Changes in Tau Has Significant Effects on Its Polymerization

BIOCHEMISTRY. 2009 JUN 30; 48 (25): 6002-6011

1076

23273 Gasser T

Mendelian forms of Parkinson's disease

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2009 JUL; 1792 (7): 587-596

154

1077

23415 Rao JN, Kim YE, Park LS, Ulmer TS

Effect of Pseudorepeat Rearrangement on alpha-Synuclein Misfolding, Vesicle Binding, and Micelle Binding

JOURNAL OF MOLECULAR BIOLOGY. 2009 JUL 17; 390 (3): 516-529

1078

23676 Mitchell AJ

CSF phosphorylated tau in the diagnosis and prognosis of mild cognitive impairment and Alzheimer's disease: a meta-analysis of 51 studies

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2009 SEP; 80 (9): 966-975

1079

23793 Scott LE, Orvig C

Medicinal Inorganic Chemistry Approaches to Passivation and Removal of Aberrant Metal Ions in Disease

CHEMICAL REVIEWS. 2009 OCT; 109 (10): 4885-4910

326

1080

23956 Whitwell JL, Przybelski SA, Weigand SD, Ivnik RJ, Vemuri P, et al.

Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: a cluster analysis study

BRAIN. 2009 NOV; 132: 2932-2946

Date / Author / Journal

LCS

GCS

LCR

1081

24558 Nelson PT, Abner EL, Schmitt FA, Kryscio RJ, Jicha GA, et al.

Modeling the Association between 43 Different Clinical and Pathological Variables and the Severity of Cognitive Impairment in a Large Autopsy Cohort of Elderly Persons

BRAIN PATHOLOGY. 2010 JAN; 20 (1): 66-79

129

1082

24601 Gabelle A, Portet F, Berr C, Touchon J

NEURODEGENERATIVE DEMENTIA AND PARKINSONISM

JOURNAL OF NUTRITION HEALTH & AGING. 2010 JAN; 14 (1): 37-44

1083

24608 Jack CR, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, et al.

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

LANCET NEUROLOGY. 2010 JAN; 9 (1): 119-128

116

1084

24616 Metcalfe MJ, Figueiredo-Pereira ME

Relationship Between Tau Pathology and Neuroinflammation in Alzheimer's Disease

MOUNT SINAI JOURNAL OF MEDICINE. 2010 JAN-FEB; 77 (1): 50-58

1085

24905 Zhou WB, Long CM, Reaney SH, Di Monte DA, Fink AL, et al.

Methionine oxidation stabilizes non-toxic oligomers of alpha-synuclein through strengthening the auto-inhibitory intra-molecular long-range interactions

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2010 MAR; 1802 (3): 322-330

1086

25384 Giehm L, Otzen DE

Strategies to increase the reproducibility of protein fibrillization in plate reader assays

ANALYTICAL BIOCHEMISTRY. 2010 MAY 15; 400 (2): 270-281

1087

25490 Gu ZZ, Nakamura T, Lipton SA

Redox Reactions Induced by Nitrosative Stress Mediate Protein Misfolding and Mitochondrial Dysfunction in Neurodegenerative Diseases

MOLECULAR NEUROBIOLOGY. 2010 JUN; 41 (2-3): 55-72

196

1088

25494 Frautschy SA, Cole GM

Why Pleiotropic Interventions are Needed for Alzheimer's Disease

MOLECULAR NEUROBIOLOGY. 2010 JUN; 41 (2-3): 392-409

201

1089

25867 Suarez I, Bodega G, Fernandez B

Upregulation of alpha-synuclein expression in the rat cerebellum in experimental hepatic encephalopathy

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2010 AUG; 36 (5): 422-435

1090

26370 Bandyopadhyay S, Huang XD, Lahiri DK, Rogers JT

Novel drug targets based on metallobiology of Alzheimer's disease

EXPERT OPINION ON THERAPEUTIC TARGETS. 2010 NOV; 14 (11): 1177-1197

230

Date / Author / Journal

LCS

GCS

LCR

1091

26403 Dubois B, Feldman HH, Jacova C, Cummings JL, DeKosky ST, et al.

Revising the definition of Alzheimer's disease: a new lexicon

LANCET NEUROLOGY. 2010 NOV; 9 (11): 1118-1127

1092

26611 Hasegawa T, Baba T, Kobayashi M, Konno M, Sugeno N, et al.

Role of TPPP/p25 on alpha-synuclein-mediated oligodendroglial degeneration and the protective effect of SIRT2 inhibition in a cellular model of multiple system atrophy

NEUROCHEMISTRY INTERNATIONAL. 2010 DEC; 57 (8): 857-866

1093

26877 Mackenzie IRA, Munoz DG, Kusaka H, Yokota O, Ishihara K, et al.

Distinct pathological subtypes of FTLD-FUS

ACTA NEUROPATHOLOGICA. 2011 FEB; 121 (2): 207-218

1094

26903 Ballatore C, Brunden KR, Trojanowski JQ, Lee VMY, Smith AB, et al.

Modulation of Protein-Protein Interactions as a Therapeutic Strategy for the Treatment of Neurodegenerative Tauopathies

CURRENT TOPICS IN MEDICINAL CHEMISTRY. 2011 FEB; 11 (3): 317-330

130

1095

3779 YEN SH, LIU WK, HALL FL, YAN SD, STERN D, et al.

ALZHEIMER NEUROFIBRILLARY LESIONS - MOLECULAR NATURE AND POTENTIAL ROLES OF DIFFERENT COMPONENTS

NEUROBIOLOGY OF AGING. 1995 MAY-JUN; 16 (3): 381-387

1096

3780 ANDERTON BH, BRION JP, COUCK AM, DAVIS DR, GALLO JM, et al.

MODULATION OF PHF-LIKE TAU PHOSPHORYLATION IN CULTURED NEURONS AND TRANSFECTED CELLS

NEUROBIOLOGY OF AGING. 1995 MAY-JUN; 16 (3): 389-397

1097

5682 Shea TB, Didier M

Biphasic effects of phosphatase inhibition on accumulation of tau phospho-isoforms in cultured cerebellar neurons

NEUROSCIENCE RESEARCH COMMUNICATIONS. 1998 JAN-FEB; 22 (1): 39-44

1098

5862 Ince PG, Perry EK, Morris CM

Dementia with Lewy bodies. A distinct non-Alzheimer dementia syndrome?

BRAIN PATHOLOGY. 1998 APR; 8 (2): 299-324

278

1099

6764 Jicha GA, O'Donnell A, Weaver C, Angeletti R, Davies P

Hierarchical phosphorylation of recombinant tau by the paired-helical filament-associated protein kinase is dependent on cyclic AMP-dependent protein kinase

JOURNAL OF NEUROCHEMISTRY. 1999 JAN; 72 (1): 214-224

1100

7111 Kampers T, Pangalos M, Geerts H, Wiech H, Mandelkow E

Assembly of paired helical filaments from mouse tau: implications for the neurofibrillary pathology in transgenic mouse models for Alzheimer's disease

FEBS LETTERS. 1999 MAY 14; 451 (1): 39-44

Trojanowski w/citing papers Publications by JQ Trojanowski and the papers citing JQ Trojanowski	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 336329, GCS 1007154, CR 1762209 Collection span: 1973 - 2011
List of All Records